--- title: InnoSer news | News description: News | Preclinical contract research organisation InnoSer, updating on new readouts, preclinical research models, preclinical drug development platforms and getting the most out of your preclinical research. --- [Skip to content](https://resources.innoserlaboratories.com/innoser-news/tag/news#main-content) InnoSer International B.V Open main navigation Close main navigation - [Contact us](https://resources.innoserlaboratories.com/innoser-news/tag/news#contact) [Contact us](https://resources.innoserlaboratories.com/innoser-news/tag/news#contact) # Blog Lorem ipsum dolor sit amet, consectetur adipiscing elit. [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/InnoSer-x-Sylics-.png)](https://resources.innoserlaboratories.com/innoser-news/news/innoser-expands-its-preclinical-neuroscience-expertise-with-the-acquisition-of-sylics) [laboratory technical support](https://resources.innoserlaboratories.com/innoser-news/tag/laboratory-technical-support), [in vivo services](https://resources.innoserlaboratories.com/innoser-news/tag/in-vivo-services), [News](https://resources.innoserlaboratories.com/innoser-news/tag/news) ## [InnoSer expands its preclinical neuroscience expertise with the acquisition of Sylics](https://resources.innoserlaboratories.com/innoser-news/news/innoser-expands-its-preclinical-neuroscience-expertise-with-the-acquisition-of-sylics) [Casey](https://resources.innoserlaboratories.com/innoser-news/author/casey) Jan 12, 2023 11:10:00 AM This strategic acquisition substantially expands InnoSer’s preclinical neurology portfolio, adding i... [Read more](https://resources.innoserlaboratories.com/innoser-news/news/innoser-expands-its-preclinical-neuroscience-expertise-with-the-acquisition-of-sylics) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/Inficure-PR@2x.png)](https://resources.innoserlaboratories.com/innoser-news/news/innoser-and-inficure-bio-liver-inflammation-fibrosis-mouse-model) [Cardio-Metabolic](https://resources.innoserlaboratories.com/innoser-news/tag/cardio-metabolic), [News](https://resources.innoserlaboratories.com/innoser-news/tag/news) ## [InnoSer and Inficure Bio enter partnership to increase accessibility of translational liver inflammation & fibrosis mouse model](https://resources.innoserlaboratories.com/innoser-news/news/innoser-and-inficure-bio-liver-inflammation-fibrosis-mouse-model) [Casey](https://resources.innoserlaboratories.com/innoser-news/author/casey) Oct 27, 2022 11:45:00 AM October 27th [Read more](https://resources.innoserlaboratories.com/innoser-news/news/innoser-and-inficure-bio-liver-inflammation-fibrosis-mouse-model) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/Transcend-parkinsons.png)](https://resources.innoserlaboratories.com/innoser-news/rnd/grants/transcend-organoid-mouse-parkinsons-drug-development) [Blog](https://resources.innoserlaboratories.com/innoser-news/tag/blog), [Grants](https://resources.innoserlaboratories.com/innoser-news/tag/grants), [In Vivo](https://resources.innoserlaboratories.com/innoser-news/tag/in-vivo), [News](https://resources.innoserlaboratories.com/innoser-news/tag/news), [Neurology](https://resources.innoserlaboratories.com/innoser-news/tag/neurology) ## [TRANSCEND: developing a novel platform integrating organoid and humanized in vivo models for Parkinson’s Disease](https://resources.innoserlaboratories.com/innoser-news/rnd/grants/transcend-organoid-mouse-parkinsons-drug-development) [admin](https://resources.innoserlaboratories.com/innoser-news/author/admin) Jun 29, 2021 1:44:38 PM The TRANSCEND project aims to tackle the current limitations of drug development for Parkinson’s Dis... [Read more](https://resources.innoserlaboratories.com/innoser-news/rnd/grants/transcend-organoid-mouse-parkinsons-drug-development) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/InnoSer-new-slogan.png)](https://resources.innoserlaboratories.com/innoser-news/news/on-a-mission-to-bring-smart-science-to-patients-a-new-chapter-in-innoser-history) [Blog](https://resources.innoserlaboratories.com/innoser-news/tag/blog), [Events](https://resources.innoserlaboratories.com/innoser-news/tag/events), [News](https://resources.innoserlaboratories.com/innoser-news/tag/news) ## [On a mission to bring smart science to patients: a new chapter in InnoSer history](https://resources.innoserlaboratories.com/innoser-news/news/on-a-mission-to-bring-smart-science-to-patients-a-new-chapter-in-innoser-history) [admin](https://resources.innoserlaboratories.com/innoser-news/author/admin) Jun 24, 2021 3:47:35 PM As the InnoSer team, we are delighted to share the news – as of this week, we have a renewed vision ... [Read more](https://resources.innoserlaboratories.com/innoser-news/news/on-a-mission-to-bring-smart-science-to-patients-a-new-chapter-in-innoser-history) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/InnoSer-Blog-and-Socials.png)](https://resources.innoserlaboratories.com/innoser-news/rnd/nano-project-ends-with-promising-results) [ALS](https://resources.innoserlaboratories.com/innoser-news/tag/als), [Grants](https://resources.innoserlaboratories.com/innoser-news/tag/grants), [brain-on-chip](https://resources.innoserlaboratories.com/innoser-news/tag/brain-on-chip), [News](https://resources.innoserlaboratories.com/innoser-news/tag/news), [Neurology](https://resources.innoserlaboratories.com/innoser-news/tag/neurology) ## [Nano+ Project Ends With Promising Results](https://resources.innoserlaboratories.com/innoser-news/rnd/nano-project-ends-with-promising-results) [Casey](https://resources.innoserlaboratories.com/innoser-news/author/casey) May 3, 2021 7:30:05 PM Currently with no known cure, Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative... [Read more](https://resources.innoserlaboratories.com/innoser-news/rnd/nano-project-ends-with-promising-results) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/InnoSer-Blog-and-Socials-2-2.png)](https://resources.innoserlaboratories.com/innoser-news/events/innoser-is-at-aacr-with-its-oncology-offerings) [Events](https://resources.innoserlaboratories.com/innoser-news/tag/events), [blastomabrain](https://resources.innoserlaboratories.com/innoser-news/tag/blastomabrain), [cancer](https://resources.innoserlaboratories.com/innoser-news/tag/cancer), [AACR](https://resources.innoserlaboratories.com/innoser-news/tag/aacr), [News](https://resources.innoserlaboratories.com/innoser-news/tag/news) ## [InnoSer is at AACR with its Oncology Offerings](https://resources.innoserlaboratories.com/innoser-news/events/innoser-is-at-aacr-with-its-oncology-offerings) [Casey](https://resources.innoserlaboratories.com/innoser-news/author/casey) Apr 7, 2021 1:42:15 PM Innoser is putting oncology development at the forefront of our efforts this year. By attending this... [Read more](https://resources.innoserlaboratories.com/innoser-news/events/innoser-is-at-aacr-with-its-oncology-offerings) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/InnoSer-Webinars.png)](https://resources.innoserlaboratories.com/innoser-news/news/innoser-brings-pathology-services) [News](https://resources.innoserlaboratories.com/innoser-news/tag/news) ## [InnoSer and its sister company C-Path to offer pathology services in close partnership](https://resources.innoserlaboratories.com/innoser-news/news/innoser-brings-pathology-services) [Casey](https://resources.innoserlaboratories.com/innoser-news/author/casey) Apr 1, 2021 12:20:14 PM Press release | Diepenbeek, 01 April 2021 [Read more](https://resources.innoserlaboratories.com/innoser-news/news/innoser-brings-pathology-services) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/BlastomaBrain-Blog.png)](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/blastomabrain-new-in-vitro-platform-for-oncology-drug-development) [Blog](https://resources.innoserlaboratories.com/innoser-news/tag/blog), [glioblastoma](https://resources.innoserlaboratories.com/innoser-news/tag/glioblastoma), [blastomabrain](https://resources.innoserlaboratories.com/innoser-news/tag/blastomabrain), [News](https://resources.innoserlaboratories.com/innoser-news/tag/news), [Neurology](https://resources.innoserlaboratories.com/innoser-news/tag/neurology) ## [BlastomaBrain: New in vitro platform for oncology drug development](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/blastomabrain-new-in-vitro-platform-for-oncology-drug-development) [admin](https://resources.innoserlaboratories.com/innoser-news/author/admin) Feb 23, 2021 3:00:23 PM One of the greatest challenges in drug development is ensuring that the safety and efficacy results ... [Read more](https://resources.innoserlaboratories.com/innoser-news/innoser-offerings/blastomabrain-new-in-vitro-platform-for-oncology-drug-development) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/InnoSer-Neurix-Partnership.png)](https://resources.innoserlaboratories.com/innoser-news/news/press-release-innoser-neurix-neural-oragnoids-oncology-drug) [News](https://resources.innoserlaboratories.com/innoser-news/tag/news) ## [Press Release: InnoSer and Neurix form a partnership to offer neural organoids for oncology drug development applications](https://resources.innoserlaboratories.com/innoser-news/news/press-release-innoser-neurix-neural-oragnoids-oncology-drug) [admin](https://resources.innoserlaboratories.com/innoser-news/author/admin) Jan 25, 2021 1:16:31 PM Press release | Leiden, 25 January 2021 [Read more](https://resources.innoserlaboratories.com/innoser-news/news/press-release-innoser-neurix-neural-oragnoids-oncology-drug) [![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/imaging-capabilities-2.png)](https://resources.innoserlaboratories.com/innoser-news/news/innoser-offers-new-in-vivo-imaging-capabilities) [News](https://resources.innoserlaboratories.com/innoser-news/tag/news), [imaging](https://resources.innoserlaboratories.com/innoser-news/tag/imaging) ## [InnoSer offers in vivo and in vitro imaging capabilities](https://resources.innoserlaboratories.com/innoser-news/news/innoser-offers-new-in-vivo-imaging-capabilities) [admin](https://resources.innoserlaboratories.com/innoser-news/author/admin) Nov 20, 2020 2:44:35 PM InnoSer is acquiring a variety of preclinical imaging modalities for its Diepenbeek facility to offe... [Read more](https://resources.innoserlaboratories.com/innoser-news/news/innoser-offers-new-in-vivo-imaging-capabilities) First Prev [1](https://resources.innoserlaboratories.com/innoser-news/tag/news) [2](https://resources.innoserlaboratories.com/innoser-news/tag/news/page/2) [3](https://resources.innoserlaboratories.com/innoser-news/tag/news/page/3) [Next](https://resources.innoserlaboratories.com/innoser-news/tag/news/page/2) [Last](https://resources.innoserlaboratories.com/innoser-news/tag/news/page/3) ## Drive people to your products and services Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Learn more facebook-f icon linkedin-in icon Twitter icon instagram icon - Menu Item 1 - Sub-menu Item 1 - Another Item - Sub-menu Item 2 - Menu Item 2 - Yet Another Item - Menu Item 3 - Menu Item 4 --- # InnoSer International B.V 123 Main Street, City, State 11111 Copyright © 2026,